This week on The Heavy Truth, Ben and Amy crack open the biggest obesity medicine news since someone looked at a weekly injection and said, "There has to be an easier way."

Enter Foundayo™ (orforglipron) — Eli Lilly's brand-new oral GLP-1 weight loss pill. No needles. No refrigeration. No timing your breakfast like you're defusing a bomb. Just a once-daily tablet that can be taken anytime, with or without food or water.

Ben and Amy break down:

What exactly Foundayo is and how it works
Why this isn't "Ozempic in a pill"
The surprising science behind a GLP-1 tablet that doesn't require fasting
The ATTAIN-1 trial results, where patients lost an average of about 12.4% of their body weight, with some losing considerably more.
How it compares to injectable medications like Zepbound and Wegovy
Common side effects and who may be a good candidate
The pricing, insurance questions, and whether this could finally make obesity treatment more accessible to millions of people who never wanted an injection.

Plus, Ben and Amy discuss the real question everyone's asking:

If a GLP-1 shot becomes a GLP-1 pill, does your medicine cabinet officially become a weight-loss pharmacy?

Whether you're needle-phobic, GLP-curious, or just wondering if "Foundayo" sounds more like a dance move than a medication, this episode delivers everything you need to know about the newest player in the obesity treatment game.

Spoiler Alert: The future of weight management may fit in your pocket.

"Take one tablet daily. Side effects may include reduced hunger, increased hope, and suddenly noticing how many commercials feature pizza." 🍕💊

#TheHeavyTruth #Foundayo #Orforglipron #GLP1 #WeightLoss #ObesityMedicine #Lilly #BenAndAmy #NoNeedlesNeeded